134 related articles for article (PubMed ID: 32659363)
1. Achieving effective informed oversight by DMCs in COVID clinical trials.
DeMets DL; Fleming TR
J Clin Epidemiol; 2020 Oct; 126():167-171. PubMed ID: 32659363
[TBL] [Abstract][Full Text] [Related]
2. Issues in data monitoring and interim analysis of trials.
Grant AM; Altman DG; Babiker AB; Campbell MK; Clemens FJ; Darbyshire JH; Elbourne DR; McLeer SK; Parmar MK; Pocock SJ; Spiegelhalter DJ; Sydes MR; Walker AE; Wallace SA;
Health Technol Assess; 2005 Mar; 9(7):1-238, iii-iv. PubMed ID: 15763038
[TBL] [Abstract][Full Text] [Related]
3. [Data monitoring committees-state of the art and perspectives for the future].
Fischer T
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Dec; 63(12):1511-1518. PubMed ID: 32897407
[TBL] [Abstract][Full Text] [Related]
4. The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea.
Jeon J; Kim H; Yu KS
J Korean Med Sci; 2020 Sep; 35(36):e329. PubMed ID: 32924344
[TBL] [Abstract][Full Text] [Related]
5. Clinical trials and the COVID-19 pandemic.
Retsas S
Hell J Nucl Med; 2020; 23(1):4-5. PubMed ID: 32361715
[TBL] [Abstract][Full Text] [Related]
6. It is unprecedented: trial management during the COVID-19 pandemic and beyond.
Mitchell EJ; Ahmed K; Breeman S; Cotton S; Constable L; Ferry G; Goodman K; Hickey H; Meakin G; Mironov K; Quann N; Wakefield N; McDonald A
Trials; 2020 Sep; 21(1):784. PubMed ID: 32917258
[TBL] [Abstract][Full Text] [Related]
7. Moving fast but going slow: coordination challenges for trials of COVID-19 post-exposure prophylaxis.
Tan DHS; Agrawal R; Barnabas RV; Giles JT; Dull P
Trials; 2020 Sep; 21(1):815. PubMed ID: 32993804
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 Ethics and Research.
Meagher KM; Cummins NW; Bharucha AE; Badley AD; Chlan LL; Wright RS
Mayo Clin Proc; 2020 Jun; 95(6):1119-1123. PubMed ID: 32402511
[No Abstract] [Full Text] [Related]
9. Clinical Trial End Points in Severe COVID-19.
Desai A; Kulkarni A; Rajkumar SV; Gyawali B
Mayo Clin Proc; 2020 Aug; 95(8):1578-1580. PubMed ID: 32753131
[No Abstract] [Full Text] [Related]
10. Editorial: Clinical trial design in the era of COVID-19.
Begg CB; Gonen M; Heitjan DF
Clin Trials; 2020 Oct; 17(5):465-466. PubMed ID: 32650671
[No Abstract] [Full Text] [Related]
11. Data Safety Monitoring during Covid-19: Keep On Keeping On.
Barnbaum DR
Ethics Hum Res; 2020 May; 42(3):43-44. PubMed ID: 32421950
[No Abstract] [Full Text] [Related]
12. How to safely and smoothly resume trials after the COVID-19 outbreak.
Wang Z; Chen G; Liu X; Du A; Li M; Wang J
J Glob Health; 2020 Dec; 10(2):020310. PubMed ID: 33110514
[No Abstract] [Full Text] [Related]
13. Randomized Clinical Trials and COVID-19: Managing Expectations.
Bauchner H; Fontanarosa PB
JAMA; 2020 Jun; 323(22):2262-2263. PubMed ID: 32364561
[No Abstract] [Full Text] [Related]
14. "You have to keep your nerve on a DMC." Challenges for Data Monitoring Committees in neonatal intensive care trials: Qualitative accounts from the BRACELET Study.
Snowdon C; Brocklehurst P; Tasker RC; Ward Platt M; Elbourne D
PLoS One; 2018; 13(7):e0201037. PubMed ID: 30048484
[TBL] [Abstract][Full Text] [Related]
15. In the COVID-19 era, let's keep an eye on clinical trials in Africa.
Agoro R
J Glob Health; 2020 Dec; 10(2):020312. PubMed ID: 33110516
[No Abstract] [Full Text] [Related]
16. [Guide for the prevention and treatment of coronavirus disease 2019].
;
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jun; 43(6):473-489. PubMed ID: 32486556
[TBL] [Abstract][Full Text] [Related]
17. [Implications of the COVID-19 pandemic for cancer in Spain].
Petrova D; Pérez-Gómez B; Pollán M; Sánchez MJ
Med Clin (Barc); 2020 Sep; 155(6):263-266. PubMed ID: 32444323
[No Abstract] [Full Text] [Related]
18. Extubation of patients with COVID-19.
D'Silva DF; McCulloch TJ; Lim JS; Smith SS; Carayannis D
Br J Anaesth; 2020 Jul; 125(1):e192-e195. PubMed ID: 32303376
[No Abstract] [Full Text] [Related]
19. Oncology Clinical Trials During the COVID-19 Pandemic.
Lara Gongoria AB; Fontes Jardim DL; Bastos DA
Oncology (Williston Park); 2020 Jul; 34(7):265-269. PubMed ID: 32674214
[TBL] [Abstract][Full Text] [Related]
20. Highly efficient clinical trial designs for reliable screening of under-performing treatments: Application to the COVID-19 Pandemic.
Piantadosi S
Clin Trials; 2020 Oct; 17(5):483-490. PubMed ID: 32666816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
